Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss EstimatesZacks Investment Research • 02/26/26
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 02/19/26
Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual ConferenceGlobeNewsWire • 01/15/26
Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025The Motley Fool • 01/14/26
Collegium Pharmaceutical, Inc. (COLL) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 12/04/25
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q3 EarningsZacks Investment Research • 11/06/25
Collegium Pharmaceutical (COLL) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/06/25
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 10/30/25
Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute ConferencesGlobeNewsWire • 10/22/25
All You Need to Know About Collegium Pharmaceutical (COLL) Rating Upgrade to Strong BuyZacks Investment Research • 09/25/25
Collegium Pharmaceutical, Inc. (COLL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25